INTRODUCTION: Acute hepatitis A is a worldwide public health problem especially in developing countries. Recently, a large, community-wide outbreak of hepatitis A occurred in the northeast part of Thailand. METHODS: Demographic and clinical data as well as blood samples were collected and analyzed from patients with acute hepatitis who attended the Buengkan Provincial Hospital from June to September 2012. About 1619 patients with clinical symptoms of hepatitis A visited the hospital during the outbreak which manifested in three waves. Blood samples were collected from 205 patients. RESULTS: One hundred and seventy eight patients had hepatitis A confirmed by the presence of anti-hepatitis A virus (HAV) IgM and/or HAV-RNA. The sensitivities for anti-HAV IgM and HAV-RNA were 95·5% (170/178) and 61·8% (110/178), respectively. When HAV-RNA was combined with anti-HAV IgM test, this increased the diagnostic yield by 7·2% (8/111) in the early phase of the acute infection (less than 5 days). Investigation of the molecular structure of the detected viruses indicated that all of the infections were caused by HAV genotype IA. There were no fatalities from this outbreak. Rapid detection, health education, sanitation campaigns, and vaccination offered on a voluntary basis have steadily reduced the number of infected patients and stopped the outbreak. CONCLUSION: Occasionally a large-scale outbreak of HAV genotype IA can occur. A combination of HAV-RNA and anti-HAV IgM tests can increase the diagnostic yield during the early phase of the acute infection. Early diagnosis and preventive management campaigns can slow down and stop the outbreak.
INTRODUCTION:Acute hepatitis A is a worldwide public health problem especially in developing countries. Recently, a large, community-wide outbreak of hepatitis A occurred in the northeast part of Thailand. METHODS: Demographic and clinical data as well as blood samples were collected and analyzed from patients with acute hepatitis who attended the Buengkan Provincial Hospital from June to September 2012. About 1619 patients with clinical symptoms of hepatitis A visited the hospital during the outbreak which manifested in three waves. Blood samples were collected from 205 patients. RESULTS: One hundred and seventy eight patients had hepatitis A confirmed by the presence of anti-hepatitis A virus (HAV) IgM and/or HAV-RNA. The sensitivities for anti-HAV IgM and HAV-RNA were 95·5% (170/178) and 61·8% (110/178), respectively. When HAV-RNA was combined with anti-HAV IgM test, this increased the diagnostic yield by 7·2% (8/111) in the early phase of the acute infection (less than 5 days). Investigation of the molecular structure of the detected viruses indicated that all of the infections were caused by HAV genotype IA. There were no fatalities from this outbreak. Rapid detection, health education, sanitation campaigns, and vaccination offered on a voluntary basis have steadily reduced the number of infectedpatients and stopped the outbreak. CONCLUSION: Occasionally a large-scale outbreak of HAV genotype IA can occur. A combination of HAV-RNA and anti-HAV IgM tests can increase the diagnostic yield during the early phase of the acute infection. Early diagnosis and preventive management campaigns can slow down and stop the outbreak.
Authors: Charlotte Wheeler; Tara M Vogt; Gregory L Armstrong; Gilberto Vaughan; Andre Weltman; Omana V Nainan; Virginia Dato; Guoliang Xia; Kirsten Waller; Joseph Amon; Teresa M Lee; Angela Highbaugh-Battle; Cambria Hembree; Stephanie Evenson; Michael A Ruta; Ian T Williams; Anthony E Fiore; Beth P Bell Journal: N Engl J Med Date: 2005-09-01 Impact factor: 91.245
Authors: A Theamboonlers; P Rianthavorn; S Jiamsiri; S Kumthong; P Silaporn; C Thongmee; Y Poovorawan Journal: Trop Biomed Date: 2009-12 Impact factor: 0.623
Authors: Rosemary Adamson; Vasudha Reddy; Lucretia Jones; Mike Antwi; Brooke Bregman; Don Weiss; Michael Phillips; Harold W Horowitz Journal: Am J Public Health Date: 2010-05-13 Impact factor: 9.308
Authors: K Barameechai; P Sa-Nguanmoo; K Suwannakarn; C Thongmee; S Payungporn; V Chongsrisawat; A Theamboonlers; Y Poovorawan Journal: Ann Trop Med Parasitol Date: 2008-04
Authors: John C Victor; Arnold S Monto; Tatiyana Y Surdina; Saida Z Suleimenova; Gilberto Vaughan; Omana V Nainan; Michael O Favorov; Harold S Margolis; Beth P Bell Journal: N Engl J Med Date: 2007-10-18 Impact factor: 91.245
Authors: Bharti Malhotra; Anu Kanwar; P V Janardhan Reddy; Aradhana Chauhan; Jitendra Tiwari; Shipra Bhargava; H N Verma Journal: Indian J Med Res Date: 2018-05 Impact factor: 2.375